Solteq Oyj
XBER:B3M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Solteq Oyj
XBER:B3M
|
FI |
|
Shenzhen Edge Medical Co Ltd
HKEX:2675
|
CN |
|
A
|
Amper SA
XMUN:APR
|
ES |
|
G
|
GeneralFinance SpA
MIL:GF
|
IT |
|
WSFS Financial Corp
F:WF4
|
US |
|
L
|
Lim Seong Hai Capital Bhd
KLSE:LSH
|
MY |
|
F
|
Freehold Royalties Ltd
F:1FH
|
CA |
|
Daishi Hokuetsu Financial Group Inc
TSE:7327
|
JP |
|
P
|
Prosperity Bancshares Inc
F:PPY
|
US |
|
Nedap NV
AEX:NEDAP
|
NL |
|
S
|
Sutro Biopharma Inc
F:S09
|
US |
Wall St Price Targets
B3M Price Targets Summary
Solteq Oyj
According to Wall Street analysts, the average 1-year price target for B3M is 0.509 EUR with a low forecast of 0.392 EUR and a high forecast of 0.641 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B3M's stock price target?
Price Target
0.509
EUR
According to Wall Street analysts, the average 1-year price target for B3M is 0.509 EUR with a low forecast of 0.392 EUR and a high forecast of 0.641 EUR.
What is the Revenue forecast for Solteq Oyj?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Solteq Oyj?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 8 years is 29%.